CRYPTOSPORIDIUM PARVUM - ANVISA Registration 80105220131
Access comprehensive regulatory information for CRYPTOSPORIDIUM PARVUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80105220131 and manufactured by KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA. The registration is held by KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, HYSEN BIOTECH.LNC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80105220131
25351189159202318
04299232000143
Company Information
Dates and Status
May 02, 2023
VIGENTE
09/18/2025 19:00:01
CRYPTOSPORIDIUM PARVUM
Cryptosporidium Antigen Rapid Test Cassette
HYSEN BIOTECH.LNC
80464810924
Jun 30, 2025
CRYPTOSPORIDIUM PARVUM
RIDASCREENยฎ Cryptosporidium
R-BIOPHARM AG
82890930010
Apr 28, 2025
CRYPTOSPORIDIUM PARVUM
CRYPTOSPORIDIUM II
TECHLAB, INC
80001590006
Oct 20, 2022
CRYPTOSPORIDIUM PARVUM
RIDASCREEN CRYPTOSPORIDIUM
R-BIOPHARM AG
80826840116
Oct 21, 2019
CRYPTOSPORIDIUM PARVUM
FAMรLIA RIDA QUICK CRYPTOSPORIDIUM CASSETE/TIRAS
R-BIOPHARM AG
80826840127
Oct 21, 2019

